dpp4i and glp 1 agonist GLP-1 receptor versus DPP-4 inhibitor kidney and cardiovascular outcomes in clinical practice in type-2 diabetes GLP-1-RA and DPP-4 inhibitors in
Description
Funding This research was funded by the NSFC (No
It is also reasonable to assume this risk is greater the deeper the depth of sedation when the patients protective reflexes that prevent aspiration are less intact
Defining inflammatory cell States in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
( n = 6 each group) and analysed using a one-way analysis of variance and Dunnetts post hoc test
10.1111/j.1742-1241.2010.02382.x [DOI] [PMC free article] [PubMed] [Google Scholar] 44.Nauck MA, Meier JJ
